Cargando…
Pretherapeutic gamma-glutamyltransferase is an independent prognostic factor for patients with renal cell carcinoma
BACKGROUND: Gamma-glutamyltransferase (GGT) regulates apoptotic balance and promotes cancer progression and invasion. Higher pretherapeutic GGT serum levels have been associated with worse outcomes in various malignancies, but there are no data for renal cell carcinoma (RCC). METHODS: Pretherapeutic...
Autores principales: | Hofbauer, S L, Stangl, K I, de Martino, M, Lucca, I, Haitel, A, Shariat, S F, Klatte, T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200090/ https://www.ncbi.nlm.nih.gov/pubmed/25117808 http://dx.doi.org/10.1038/bjc.2014.450 |
Ejemplares similares
-
Prognostic impact of pretherapeutic gamma-glutamyltransferase on patients with nasopharyngeal carcinoma
por: Wen, Yue-Feng, et al.
Publicado: (2017) -
Prognostic Relevance of Pretherapeutic Gamma-Glutamyltransferase in Patients with Primary Metastatic Breast Cancer
por: Staudigl, Christine, et al.
Publicado: (2015) -
Associations Between Presenting Symptoms, Clinicopathological Parameters, and Prognosis in a Contemporary Series of Patients With Renal Cell Carcinoma
por: Hofbauer, Sebastian L., et al.
Publicado: (2014) -
Prognostic factors in metastatic renal cell carcinoma: metastasectomy as independent prognostic variable
por: Vogl, U M, et al.
Publicado: (2006) -
Association of gamma-glutamyltransferase with severity of disease at diagnosis and prognosis of ovarian cancer
por: Grimm, C, et al.
Publicado: (2013)